SIM Acquisition Corp. I (SIMAW) 股票分析
SIM Acquisition Corp. I
$0.38
+$0.24 (+170.83%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
SIM Acquisition Corp. I (SIMAW) operates as a special purpose acquisition company focused on executing business combinations within the healthcare sector, specifically targeting mergers, share exchanges, asset acquisitions, or similar transactions with one or more entities in that industry. Although the company is classified within the broader finance sector and healthcare industry, it currently lacks significant operational activities beyond its strategic intent to complete a merger. The firm reports a market capitalization that is listed as not available, alongside annual revenue and employee counts that are similarly unquantified in the provided data. This absence of specific scale metrics, such as a defined market cap or revenue figure, indicates that the entity remains in a pre-transaction phase where traditional valuation anchors and operational footprints have not yet materialized. Consequently, the company's position in the market is defined primarily by its SPAC structure rather than by established operating performance or a large-scale workforce, reflecting the transitional nature of its current business model.
财务健康
The company reports a net income of $8.79 million for the trailing twelve months, while revenue and EBITDA figures are listed as not available. The substantial gap between the reported net income and the unlisted revenue suggests a unique cost structure typical of SPACs, where accounting adjustments or non-operating income may drive reported earnings in the absence of significant sales. Free cash flow stands at $-434,468, indicating a net cash outflow that reflects capital expenditures or working capital requirements exceeding cash generation, thereby limiting immediate financial flexibility for large-scale strategic initiatives. Margins across the board are recorded as 0.0% for gross, operating, and profit, which signifies that the company has not yet generated revenue sufficient to calculate meaningful margins or that operating expenses have effectively offset any potential profitability from existing operations. On the balance sheet, cash holdings total $65,427, while total debt is $0, resulting in a debt-to-equity ratio that is listed as not available due to the lack of equity data. This combination of minimal debt and positive cash, despite the small cash balance, points to a conservative leverage profile rather than a highly leveraged structure. However, the current ratio is 0.89, which is below the benchmark of 1.0, indicating that the company's current assets do not fully cover its current liabilities and suggesting potential short-term liquidity constraints. Return on assets is -0.3%, revealing a negative return on the asset base, while return on equity is not available due to missing equity figures. These return metrics collectively suggest that management effectiveness in generating returns from the available asset base has been negative, a common characteristic for shell companies awaiting a target acquisition.
估值评估
The trailing P/E ratio and forward P/E are both listed as not available, implying that standard earnings-based valuation models cannot be applied to assess the expected earnings trajectory given the current financial reporting status. The price-to-book ratio is -0.70, a negative figure that indicates the market price is significantly below the book value, a scenario often seen in SPACs where the trust value might be lower than the capitalized stock price or where book value calculations are distorted by specific accounting treatments. Price-to-sales and EV/EBITDA metrics are also not available, preventing a comparison with traditional valuation multiples and suggesting that alternative metrics are the only viable options for assessing value in this early-stage entity. The 52-week high and 52-week low are both recorded at $0.25, meaning the stock price has remained static at this level, trading at 0% deviation from the 52-week range. The beta value is not available, which prevents a quantitative assessment of price volatility relative to the broader market but implies that historical volatility data may be insufficient or non-existent for a newly incorporated entity. These valuation characteristics highlight the speculative nature of the stock, where traditional financial ratios fail to provide insight, and the price action is strictly confined to a narrow band around the trust value or initial offering price.
Growth & Income
Revenue growth year-over-year and earnings growth year-over-year are both listed as not available, making it impossible to calculate whether earnings are growing faster or slower than revenue. Since the company does not pay dividends, there is no dividend yield or payout ratio to analyze for sustainability. Instead, the company reinvests its limited resources into the pursuit of a business combination rather than distributing cash to shareholders. The overall growth and income profile is characterized by a lack of historical growth data and an absence of dividend income, reflecting the company's status as a shell entity waiting for a target acquisition to define its future growth potential.
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
关于SIM Acquisition Corp. I
SIM Acquisition Corp. I does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses in the healthcare sectors. SIM Acquisition Corp. I was incorporated in 2024 and is based in New York, New York.
公司简介以英文显示。
访问官网 →关键指标
- 市值
- N/A
- 市盈率
- N/A
- 52周最高
- $0.22
- 52周最低
- $0.14
数据由Yahoo Finance通过yfinance提供。每日更新。
公司信息
- 交易所
- NASDAQ
- 国家
- United States